4.0
19 June 2026
Current employee
Recommend
CEO approval
Business outlook
Pros
High salary, good products, pleasant people across the organization, fewer restrictive policies than some other pharma
Cons
Questionable decisions from higher management, frequent restructures, transparency is reducing every year